Arsanis, Inc., a clinical-stage biopharmaceutical company developing targeted monoclonal antibodies (mAbs) for pre-emptive and post-infection treatment of serious infectious diseases, today announced the closing of a $45.5 million Series D financing led by the Bill & Melinda Gates Foundation. Several Read More
Year: 2017
Press Release: Vir Biotechnology launches to cure, treat, and prevent challenging infectious diseases using latest advances in immunology
Vir Biotechnology January 6, 2017 Vir Biotechnology, Inc. today announced it is launching to develop cures, treatments, and preventions for challenging infectious diseases, with former Biogen CEO George Scangos heading a team of scientific and industry leaders. The company will be headquartered Read More
Press Release: Immunocore and the Bill & Melinda Gates Foundation collaborate to develop immunotherapies for infectious diseases
Immunocore September 18, 2017 Immunocore Limited, the world’s leading TCR company developing biological drugs to treat cancer, infectious diseases and autoimmune diseases, today announced an investment from the Bill & Melinda Gates Foundation to support the development of Immunocore’s soluble Read More
Update: Implant Access Program: Expanding Family Planning Options For Women
The global family planning community is working to ensure that more women around the world have access to contraceptive options and family planning services and information. As part of this global effort, a group of organizations collaborated to make contraceptive Read More
Forbes: Leaving Biogen, CEO Scangos to head new firm that battles germs
By Matthew Herper January 6, 2017 Most drug companies are retreating from the business of creating drugs against viruses and, especially, bacteria. But a well-funded startup being announced today is taking the challenge head-on. The new company, called Vir Biotechnology, Read More